Skip to content

Embecta Corp. EMBC Free cash flow yield

Free cash flow yield at other companies

Insulet logo
InsuletPODD
2.8%+1.2pp
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
-0.6%-0.2pp
Medtronic logo
MedtronicMDT
5.2%+0.4pp
Mannkind logo
MannkindMNKD
2.6%
Beta Bionics, Inc. Common Stock logo
Beta Bionics, Inc. Common StockBBNX
-13.7%
ICU Medical logo
ICU MedicalICUI
2.9%-1.0pp

Other financials

Income statement

See full
Revenue$221.8M-14.4%
Gross profit$127.8M-22.1%
Operating income$35.0M-44.4%
Net income-$4.1M-117%
EPS (diluted)-$0.07-118%

Balance sheet

See full
Cash & equivalents$193.4M-8.9%
Total debt$1.4B-12.5%
Total equity-$626.1M+15.0%
Total assets$1.0B-8.1%

Cash flow

See full
Operating cash flow$31.1M-2.2%
CapEx$500.0K+400%
Free cash flow$30.6M-3.5%

Valuation

See full
Market cap$193.41M-64.3%
Enterprise value$1.37B-24.8%
P/E1.7×-4.8×
P/S0.2×-0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin25.8%+9.7pp
Net margin10.7%+5.8pp
FCF margin19.6%+16.0pp

Returns & leverage

See full
Return on equity71.9%
Debt / equity
Current ratio2.5×0.0×

Where this comes from

Calculated from Embecta Corp.’s reported figures.

Based on trailing twelve months.

The official record: Embecta Corp.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Embecta Corp.'s free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Embecta Corp.'s free cash flow yield?
Embecta Corp. (EMBC) reported free cash flow yield of 39.1% in Q1 2026.
How has Embecta Corp.'s free cash flow yield changed year-over-year?
Embecta Corp.'s free cash flow yield increased by 630.0% year-over-year, from 5.4% to 39.1%.
What is the long-term trend for Embecta Corp.'s free cash flow yield?
Over 2 years (2022 to 2025), Embecta Corp.'s free cash flow yield has grown at a -3.2% compound annual growth rate (CAGR), from 23.6% to 22.1%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.